Charles River Laboratories International(FRA) RV6

Market Cap€12.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€266.20
-1.00%
-2.70Today

Charles River Laboratories International Financials at a Glance

Market Cap

€12.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€3.43K

Net Income (TTM)

-€203.14

EPS (TTM)

-€4.17

P/E Ratio

-64.54

Dividend

€0.00

Beta (Volatility)

-0.04 (Low)

Price

€266.20

Volume

0

Open

€266.20

Previous Close

€266.20

Daily Range

€266.20 - €266.20

52-Week Range

€127.95 - €279.60

Estimated Earnings Date

N/A

RV6 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Charles River Laboratories International

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides research models required in the research and development of new drugs, devices, and therapies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment consists of the commercial production and sale of research models, research products, and the provision of services related to the maintenance and monitoring of research models and the management of the clients’ research operations. The Discovery and Safety Assessment segment offers integrated drug discovery services directed at the identification, screening, and selection of a lead compound for drug development and offers safety assessment services, including bioanalysis, drug metabolism, pharmacokinetics, toxicology, and pathology. The Manufacturing Support segment consists of Microbial Solutions, which provides in vitro (non-animal) lot-release testing products, microbial detection products, and species identification services, Biologics Solutions, which performs specialized testing of biologics as well as contract development and manufacturing, and Avian Vaccine Services, which supplies specific-pathogen-free chicken eggs and chickens. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Industry

Life Sciences Tools and Services

Employees

19,700

CEO

Birgit Girshick, MBA

RV6 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-7.68%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-1.55%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€12.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

47.74M

Volume

0

Avg. Volume

8.697

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Charles River Laboratories International Performance Analysis

Charles River Laboratories International annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 3,783,213,28826.3%
20232023-12-31EUR 3,819,581,3551.0%
20242024-12-31EUR 3,744,128,325-2.0%
20252025-12-31EUR 3,557,912,857-5.0%
Charles River Laboratories International annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 9.0240.2%
20232023-12-31EUR 8.53-5.4%
20242024-12-31EUR 0.18-97.8%
20252025-12-31EUR -2.58N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€863.57

+0.9%

Gross Profit

€313.43

+1.1%

Gross Margin

36.29%

+1.2%

Market Cap

€12.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.43

N/A

Employees

19,700

N/A

Net Income

-€0.65

-0.0%

EBITDA

€187.09

+0.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€2.84K

+12.3%

Total Debt

€2.65K

+1.1%

Accounts Receivable

€622.54

+1.0%

Inventory

€302.86

+1.3%

Long Term Debt

€2.65K

+1.1%

Short Term Debt

€5.80

+2.3%

Return on Assets

-3.15%

+3.1%

Return on Invested Capital

3.97%

+0.6%

Free Cash Flow

€127.74

+0.9%

Operating Cash Flow

€154.79

+0.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About RV6

What is the current price of Charles River Laboratories International?

Charles River Laboratories International is trading at €266.20 per share.

What is the 52-week range for Charles River Laboratories International?

Over the past 52 weeks, Charles River Laboratories International has traded between €127.95 and €279.60.

How much debt does Charles River Laboratories International have?

As of the most recent reporting period, Charles River Laboratories International reported total debt of €2.65B.

How much cash does Charles River Laboratories International have on hand?

Charles River Laboratories International reported €189.32M in cash and cash equivalents in its most recent financial results.

What is Charles River Laboratories International’s dividend yield?

Charles River Laboratories International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.